LSI is Officially Heading to Singapore — Register for LSI Asia '25 Today
Learn More About Dicerna Pharmaceuticals
Dicerna Pharmaceuticals
image
Next-generation RNA interference (RNAi)-based therapeutics to reach previously undruggable intracellular disease targets, including cancer
Technology/product details
Revenue projections
Capital raised to date
Growth strategy
Competing Startups
More

Get a Demo and See the Full Profile

Get a demo today to see profiles of Spineology plus 6164 other startups.

Trusted By The Companies Pioneering What’s Next